Dad Approved Recombinant Human Mesothelin/msln Protein (aa 296-580, Fc Tag) Now 95% Cheaper [bHAy2cWm]

Dad Approved Recombinant Human Mesothelin/msln Protein (aa 296-580, Fc Tag) Now 95% Cheaper [bHAy2cWm]

Discover the precision and purity of our Dad Approved Recombinant Human Mesothelin/msln Protein (aa 296-580, Fc Tag) Now 95% Cheaper [bHAy2cWm]. This high-quality protein is derived from HEK293 cells, ensuring exceptional consistency and reliability. With a calculated molecular weight of 60.7 kDa and an observed molecular weight of 65 kDa, this protein is a valuable tool for research and development in the fields of oncology and cellular biology.

• Expression Host: HEK293 Cells
• Sequence: Glu296-Gly580

Unmatched Purity and Bioactivity

Our Recombinant Human Mesothelin/MSLN Protein is meticulously formulated for purity, exceeding 95% as determined by reducing SDS-PAGE. This ensures the highest level of accuracy in your research. With a low endotoxin level of less than 1.0 EU per μg, you can trust the integrity of your experiments. While the bio-activity of this protein has not been validated, its potential for use in various applications is significant.

• Storage: Stable for up to 12 months at -20 to -80℃
• Shipping: Provided as lyophilized powder with ice packs for safe delivery

Applications and Background

The Recombinant Human Mesothelin/MSLN Protein is a crucial component in understanding the role of mesothelin in various cancers, particularly mesothelioma and ovarian cancer. Its interaction with MUC16 and ability to potentiate megakaryocyte colony formation in vitro make it a valuable research tool. The protein is secreted by several mesothelioma cell lines and is frequently elevated in the blood of patients with mesothelioma, suggesting its potential use in monitoring treatment response. With its extensive background and wide range of applications, this protein is a must-have for researchers in the field of oncology.

• Properties: Greater than 95% purity and low endotoxin levels
• Use: Ideal for research in oncology, cellular biology, and mesothelioma studies